It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

Merck said Wednesday it had licensed an experimental GLP-1 obesity pill from a Chinese drugmaker ... and Novo Nordisk’s dominance in the weight-loss market. It also comes amid worries that ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...

Experts aren’t really on board with taking these new, buzzy, multi-ingredient supplements that claim to help with insulin ...